|
Volumn 60, Issue 11, 2003, Pages 1871-1872
|
The pentapeptide QYNAD does not block voltage-gated sodium channels [4] (multiple letters)
a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID DERIVATIVE;
GLUTAMINE;
GLUTAMINYLTYROSYLASPARAGINYLALANYLASPARTIC ACID;
MUTANT PROTEIN;
PENTAPEPTIDE;
PYROGLUTAMIC ACID DERIVATIVE;
SODIUM CHANNEL;
SODIUM CHANNEL BLOCKING AGENT;
UNCLASSIFIED DRUG;
AMIDATION;
AMINO ACID SEQUENCE;
AMINO TERMINAL SEQUENCE;
BATCH PROCESS;
BRAIN CELL;
CEREBROSPINAL FLUID;
DRUG ACETYLATION;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INACTIVATION;
DRUG POTENCY;
DRUG PURIFICATION;
DRUG PURITY;
DRUG SYNTHESIS;
EXPERIMENTAL MODEL;
FREEZE DRYING;
GUILLAIN BARRE SYNDROME;
HETEROLOGOUS EXPRESSION;
HUMAN;
LETTER;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
METHODOLOGY;
MULTIPLE SCLEROSIS;
NEUROBLASTOMA CELL;
NONHUMAN;
PEPTIDE SYNTHESIS;
PRIORITY JOURNAL;
PROTEIN ISOLATION;
PROTEIN VARIANT;
QUANTITATIVE ANALYSIS;
ROOM TEMPERATURE;
SCIATIC NERVE;
SODIUM CURRENT;
TANDEM MASS SPECTROMETRY;
THALAMUS;
|
EID: 10744227811
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.60.11.1871-a Document Type: Letter |
Times cited : (1)
|
References (0)
|